What is a “Sequence Listing” in patent applications?

A “Sequence Listing” is a separate part of a patent application that contains disclosures of nucleotide and/or amino acid sequences, along with associated information, using a standardized format and symbols. According to MPEP 2421.01, it is required for applications containing disclosures of nucleotide and/or amino acid sequences that fall within the definitions of 37 CFR 1.821(a).

The MPEP states: 37 CFR 1.821(c) requires that applications containing disclosures of nucleotide and/or amino acid sequences that fall within the definitions of 37 CFR 1.821(a) contain, as a separate part, a disclosure of the nucleotide and/or amino acid sequences, and associated information, using the format and symbols that are set forth in 37 CFR 1.822 and 37 CFR 1.823.

To learn more:

Topics: MPEP 2400 - Biotechnology, MPEP 2421.01 - Definition Of "Sequence Listing" And Computer Readable Form (Crf), Patent Law, Patent Procedure
Tags: amino acid sequences, Biotechnology, nucleotide sequences, patent applications, sequence listing